Certified by Founder Lodge
JEITO
France - Paris, IDF
INVESTOR
1 Disclosed Funding Rounds $69,471,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact. We empower an
| Company | Date | Round | Raised |
|---|---|---|---|
 Corteria Pharmaceuticals |
September, 07 ,2023 | Series A | $69,471,000 |
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
 HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
 CatalYm GmbH |
July, 16 ,2024 | Series D | $150,000,000 |
 Aviceda Therapeutics |
January, 08 ,2025 | Series C | $207,500,000 |
 XyloCor Therapeutics, Inc. |
January, 09 ,2025 | Series B | $67,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Mondra | $13,206,500 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
